RESEARCHER PROFILE (Filmed February 2024)
Dr Karen Best,
Director & Principal Research Fellow
SAHMRI Clinical Trials Platform
SAHMRI (South Australian Health and Medical Research Institute)
Dr Karen Best is Senior Research Fellow in the South Australian Health and Medical Research Institute (SAHMRI) Women and Kids Theme. She is a Registered Midwife with a unique breadth of experience in clinical project management, academic skills and knowledge translation and is committed to better understanding the essential role that modifiable exposures in pregnancy play in setting the foundations for a healthy start to life.
Her career in the health sector began as a Registered Nurse followed by the completion of a certificate in Midwifery. As a midwife, she spent almost 10 years working in a large neonatal unit in Adelaide caring for premature babies and their families prior to becoming involved in research.
Dr Best was awarded an MS McLeod Post-doctoral Fellowship in 2019. She currently leads a program of research involving the design and conduct of innovative perinatal trials, with national and international collaboration. Her work focuses on nutritional interventions during, pregnancy and early life (first 1000 days) to ensure children have the best start to life. She is currently leading a landmark national trial of iodine supplementation in pregnancy to identify the optimal amount of iodine needed in pregnancy for infant neurodevelopment.
Dr Best’s post-doctoral role as Chief Investigator resulted in the successful completion of the largest trial in the world of Omega-3 in pregnancy to Reduce the Incidence of Prematurity (ORIP) Trial. Dr Best led this National RCT involving 5544 women from multiple participating centres, since been published in the New England Journal of Medicine. Evidence from the ORIP Trial combined with the 2018 Cochrane review of omega-3 in pregnancy has recently informed an “Omega-3 Implementation Project. Using the current evidence base and extensive consultation with health professional and consumer reference groups, we have partnered with SA Pathology to deliver a precision nutrition approach involving omega-3 testing and specific guidance for supplementation based on omega-3 status results in the first 20 weeks of gestation. The aim of the implementation project is to reduce the incidence of early preterm birth by embedding sustainable omega-3 precision nutrition strategies in pathology and maternity services.
Dr Best is an Investigator on several industry-sponsored and investigator-initiated grants totalling more than AUD$6,000,000 and involving more than 11,000 participants. These skills have been recognised internationally with invitations to speak at clinical trial workshops in the US. She has managed interdisciplinary teams and delivered complex research projects involving multiple stakeholders and in changing environments.
Dr Best’s work on omega-3 in pregnancy to prevent preterm birth Results been used to inform the update of the Australian Perinatal Guidelines and further analysis of this trial has guided an implementation project to embed precision nutrition strategy into routine antenatal care for the prevention of preterm birth.
As Director of the SAHMRI Clinical Trials Platform, Dr Best lead’s a team of dedicated Clinical Research Professionals. As Dr Best states, “Our collective vision as an Academic Research Organisation is to deliver professional, participant centred clinical trial services to SAHMRI Researchers and external clients to accelerate the translation of research into real world impact.”
You Might also like
-
Investigating invasive lobular carcinoma and metaplastic breast cancer sub-types
Assoc Prof McCart Reed is the scientific lead on an MRFF-funded (Medical Research Future Fund) genomics program investigating the potential for the application of Whole Genome Sequencing in the breast cancer care pathway in Australia, ‘Q-IMPROvE’. She applies genomics and spatial transcriptomics methodologies to archival clinical samples to understand the differences between tumour types and their potential for treatment. Amy is passionate about clinical research, biobanking and precision oncology. In addition to her breast cancer research portfolio, she is on the steering committee for the Brisbane Breast Bank and the Scientific Advisory Board for Breast Cancer Trials.
-
Public health and research into Ear, Nose and Throat conditions
Associate Professor Paul Paddle is an Ear, Nose and Throat (ENT) surgeon, head and neck surgeon with fellowship training in Laryngology – Voice, airway and Swallowing disorders. Working at Monash Health and Monash Children’s hospital, Paul has extensive experience managing a wide range of paediatric ENT conditions, from neonates to adolescents. He is also an active researcher in paediatric obstructive sleep apnoea and sleep disorders.
-
Junior Fellowship to develop vaccine for bacteria that cause ear infections
Dr Erin Brazel has a background in molecular and translational microbiology, with a focus on developing new ways of preventing and treating bacterial diseases. Recently Dr Brazel has been awarded a Junior Fellowship by the Passe & Williams Memorial Foundation.
The fellowship enables outstanding individuals to obtain postdoctoral training under the supervision of an experienced clinical or scientific researcher, with the view to establishing a research career in Otolaryngology, Head and Neck Surgery in Australia and/or New Zealand.